Progressive Multiple Sclerosis
Also known as: Progressive Multiple Sclerosis (PMS) / Multiple Sclerosis, Progressive / Progressive multiple sclerosis (disorder) / Multiple Sclerosis, Chronic Progressive
| Drug | Drug Name | Drug Description |
|---|---|---|
| DB12612 | Ozanimod | A sphingosine 1-phosphate receptor modulator being studied to treat Multiple Sclerosis (MS) and inflammatory bowel disease (IBD). |
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB00316 | Acetaminophen | 1 | Completed | 1 |
| DB00787 | Acyclovir | 1 | Completed | 3 |
| DB00087 | Alemtuzumab | 1 | Completed | 1 |
| DB13679 | Dexchlorpheniramine | 1 | Completed | 1 |
| DB00166 | Lipoic acid | 1 | Completed | 1 |
| DB00455 | Loratadine | 1 | Completed | 1 |
| DB00959 | Methylprednisolone | 1 | Completed | 1 |
| DB15726 | Human Umbilical Cord Mesenchymal Stem Cells | 1 / 2 | Unknown Status | 1 |
| DB08834 | Tauroursodeoxycholic acid | 1 / 2 | Completed | 1 |
| DB00151 | Cysteine | 2 | Completed | 1 |
| DB00959 | Methylprednisolone | 2 | Completed | 1 |
| DB00073 | Rituximab | 2 | Completed | 1 |
| DB00242 | Cladribine | 2 / 3 | Recruiting | 1 |
| DB11526 | Masitinib | 3 | Recruiting | 1 |
| DB11988 | Ocrelizumab | 3 | Active Not Recruiting | 1 |
| DB00121 | Biotin | Not Available | Unknown Status | 1 |